ClinicalTrials.gg
Active, not recruitingNCT06107634PEH3Updated Oct 26, 2026

Gastropexy in the Repair of Patients With Paraesophageal Hernias

An interventional study of Gastropexy and Paraesophageal hernia repair in Paraesophageal Hernia, sponsored by Ersta Diakoni. Active, not recruiting at 6 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Ersta Diakoni · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2023, registered Sep 2023).
Updated Oct 26, 2026Now Active, not recruitingPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional surgical hernia repair or with the addition of gastropexy.

Read the detailed description

Patients scheduled for surgery due to primary paraesophageal herniation are randomized into either the control group or the interventional group.

Control Group: Patients undergo a crural repair combined with a short and floppy Nissen fundoplication.

Interventional Group: In addition to the crural repair and Nissen fundoplication, patients receive a gastropexy. This involves the fixation of the posterior part of the wrap the right crus, the left portion of the wrap to the diaphragm, and the minor curvature of the stomach to the abdominal wall.

Follow-Up Assessments:

Imaging: Computed tomography (CT) scans are performed before surgery and at 1 and 3 years postoperatively to evaluate anatomical outcomes.

Patient-Reported Outcomes: The following questionnaires are completed before surgery, as well as at 3 months, 1 year, and 3 years after surgery:

SF-36: A global quality of life instrument. GSRS: The Gastrointestinal Symptoms Rating Scale. Reflux Frequency Questionnaire: A measure reflux disease-related symptoms. Dakkak's Dysphagia Score: An assessment of swallowing difficulties.

02

Conditions studied

  • Paraesophageal Hernia

Browse trials for

03

In context

Hernia, Hiatal

87 studies on the registry are indexed under Hernia, Hiatal; 27 are open to participants now.

This study's enrollment of 150 is above the median of 100 across 56 interventional studies indexed under Hernia, Hiatal.

Browse Hernia, Hiatal studies →

Lead sponsor

Ersta Diakoni is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients diagnosed with a primary paraesophageal hernia (hiatal hernia types II-IV) who are scheduled for elective or emergency surgical repair at participating centers

Exclusion criteria

Exclusion Criteria:

  • Previous major upper gastrointestinal (GI) surgery, including prior hiatal hernia repair.
  • Diagnosis of achalasia or any other significant esophageal motility disorder.
  • Inability to understand the purpose of the study and/or inability or unwillingness to provide .
  • Severe comorbidities, defined by an (ASA) physical status score of greater than III.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
150 participants (actual)

Study arms

  • Active comparator
    Standard paraesophageal hernia repair

    Standard paraesophageal hernia repair (crural suturing and a total (Nissen) fundoplication)

    Procedure: Paraesophageal hernia repair

  • Experimental
    Standard paraesophageal hernia repair + gastropexy

    Standard paraesophageal hernia repair with the addition of a three point gastropexy (posterior, left anterolateral and anterior gastropexy)

    Procedure: Gastropexy · Procedure: Paraesophageal hernia repair

Interventions

  • ProcedureGastropexy

    In the intervention group, a three-point gastropexy is added to the repair. First, the right fundus flap is adapted posteriorly to the crural portion of the diaphragm with a 2-3 cm long running non-absorbable suture ("posterior gastropexy"). Second, the left fundus flap is adapted to the diaphragm anterolateral to the hiatus with a 2-3 cm long running non-absorbable suture ("left anterolateral gastropexy"). Finally, the minor curvature of the anterior stomach wall is adapted during reduced intraabdominal pressure to the anterior abdominal wall with a 2-3 cm long running non-absorbable suture ("anterior gastropexy").

  • ProcedureParaesophageal hernia repair

    Ultrasonic shears are used for dissection. The herniated viscera are completely reduced into the abdomen and the hernia sac in fully dissected and resected. The esophagus is mobilized intraabdominally until at least 3 cm rests below the hiatus without tension. The anterior and posterior vagal nerves are identified and preserved. A posterior crural closure with running non-absorbable sutures is performed. An additional anterior crural closure may be performed at the surgeon's discretion. The fundus is mobilized to allow a floppy fundoplication. A total fundoplication is created by three interrupted non-absorbable sutures. No bougies are used routinely for calibration of the fundoplication.

06

What researchers measure

Primary outcomes

  1. Recurrence of hernia at 1 year after surgery

    Computer tomography of abdomen and thorax

    Time frame: 1 year

Secondary outcomes

  1. Recurrence of hernia at 3 years after surgery

    Computer tomography of abdomen and thorax

    Time frame: 3 year

  2. Complications after surgery

    Complication classified according to Clavien-Dindo

    Time frame: 30 days after surgery

  3. Length of stay at the hospital after surgery

    Information from patients journal

    Time frame: 30 days after surgery

  4. Changes in the patients perception of quality of life after surgery

    SF-36 (Short Form 36) is a health related quality of life questionnaire. SF-36 is comprised of 36 items that assess eight dimensions of health: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Higher scores mean a better outcome. These can be grouped into mental and physical component summary scores. Scoring is from 0-100. A mean score of 50 has been articulated as normative value.

    Time frame: 3 months, 12 months, and 36 months

  5. Changes in the patients perception of gastrointestinal symptoms after surgery

    GSRS (The Gastrointestinal Symptom Rating Scale) is a questionnaire, which contains 15 items, and uses a seven-graded Likert scale, where 1 represents the most positive option and 7 the most negative one. The questions are grouped in five dimensions. A mean value for the items in each dimension will be calculated: Diarrhoea syndrome: 11. Increased passage of stools 12. Loose stools 14. Urgent need for defecation Indigestion syndrome: 6. Borborygmus 7. Abdominal distension 8. Eructation 9. Increased flatus Constipation syndrome: 10. Decreased passage of stools 13. Hard stools 15. Feeling of incomplete evacuation Abdominal pain syndrome: 1. Abdominal pain 4. Sucking sensations 5. Nausea and vomiting Reflux syndrome: 2. Heartburn 3. Acid regurgitation.

    Time frame: 3 months, 12 months, and 36 months

  6. Changes in the patients perception of dysphagia after surgery

    The Dakkak dysphagia score is a questionnaire for assessing benign dysphagia, including nine questions regarding the frequency (always, sometimes, or never) of swallowing difficulties with different food consistencies (liquid, semisolid, and solid foods). The final score ranges from 0 to 45, where 45 represents the most severe dysphagia.

    Time frame: 3 months, 12 months, and 36 months

  7. Changes in the patients perception of dysphagia and reflux frequency after surgery

    Symptoms of heartburn, reflux, chest pain, dysphagia for liquids and solids, dyspnea, coughing and odynophagia were recorded using a four-graded scale to assess the frequency of symptoms with an arbitrary (empirical) cut off for clinical significance. The same instrument has been used in a previous RCT, from the same institution, comparing different types of anti-reflux procedures.

    Time frame: 3 months, 12 months, and 36 months

07

Study locations

6 sites
08

References and documents

Publications

  • Dackhammar JB, Tsoposidis A, Wallenius V, Kostic S, Cengiz Y, Linder G, Jeremiasen M, Analatos A, Lundell L, Hakanson B, Thorell A, Hansson MR. Can gastropexy reduce the recurrence rate after paraesophageal hernia repair? A study protocol for a double blind, randomized, multicenter clinical trial. Trials. 2026 Mar 16;27(1):281. doi: 10.1186/s13063-026-09578-7. PubMed 41840686 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Active, not recruiting
changed Oct 26, 2026
Primary completion
Aug 2, 2027→Oct 31, 2027
Oct 26, 2026
Study completion
Aug 2, 2030→Nov 30, 2029
Oct 26, 2026
Enrollment
124 (estimated)→150 (actual)
Oct 26, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 41840686 ↗
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Recruiting→Active, not recruiting
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 41840686 ↗
    Primary completion Aug 2, 2027→Oct 31, 2027
    Study completion Aug 2, 2030→Nov 30, 2029
    Enrollment 124 (estimated)→150 (actual)
    + 7 other changes: identifiers, verification date, oversight details, criteria formatting, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06107634
Lead sponsor
Ersta Diakoni
Collaborators
Göteborg University, Sundsvall Hospital, Karolinska Institutet
Responsible party
Marcus Reuterwall Hansson (PhD, senior consultant surgeon, Ersta Diakoni) — Principal investigator
First posted
Oct 30, 2023
Start date
Jun 1, 2023
Primary completion
Oct 31, 2027 (estimated)
Completion
Nov 30, 2029 (estimated)
Last update
Oct 26, 2026

Study contacts

Anders Thorell, Professor
study director · Ersta Diakoni

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion